2Depierre A,Jacoulet P,Camier G.Efficacy of Navelbine and vina alkaloids in the treatment of non-small-cell lung cancer(NSCLC).Onloie PF.Navelbine:Update and New Trends.1 st ed,Montrouge:John Libbty Eurotext Ltd,1991:133.
3Chevalier TL,Berthan P,Suffie P.NVB and high dose PDD in advanced non-small-cell lung cancer (NSCLC):result of phase Ⅰ-Ⅱ study and design of multicenter randomized phase Ⅲ study.J Cancer Res Cli Oncol,1990,166(Suppl part Ⅱ):1052-1056.
1Depierre A, Jacoulet P, Gamier G. Efficacy of Navelbine and vinca alkaloids in the treatment of non-small-cell lung cancer (NSCLC)[A]. Oncoloie PF. Navelbine: Update and New Trends[M]. 1st ed, Montrouge: John Libbty Eurotext Ltd,1991:133.
2Chevalier TL, Brisgand D, Dourllard JY, el at. Randomized study of vinorebline and cisplatin versus vindesine and cisplatin versus vinorebline alone in advanced non-small-cell lung cancer:results of a European multicenter trial including 612 patients[J].C
3Chevalier TL, Berthan P, Suffie P. NVB and high-dose PDD in advanced non-small-cell lung cancer (NSCLC): result of phase I-Ⅱ study and design of multicenter randomized phase Ⅲ study[J].J Cancer Res Clin Oncol, 1990,166(Suppl part Ⅱ):1052-1056.
4Wozniak A J, Crowley J J, Balcerzak SP, et al. Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer, a Southwest Oncology Group study[J]. J Clin Oncol, 1998,16(7): 2459-2465.
5Bemardo G, Cuzzoni Q, Strada MR et al. First-line chemotherapy with vinorelbine, gemcitabine and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a phase Ⅱ study [J]. Cancer Invest, 2002,20(3):293-320.
6Diana F. Current options in the treatment of non-small-cell lung cancer[J]. Drugs, 1992,44(Suppl.4),46-59.
7Krikorian A. Pharmacokinetics of navelbine[A]. Oncoloie PF.Navelbine:Update and New Trends[M]. 1st ed, Montrouge:Jonh Libbey Eurotext Ltd, 1991:43-52.
8Scarliotti GV, De Marinis F, Rinaldi M, et al. Phase Ⅲrandomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer[J]. J Clin Oncol, 2002 ,20(21):4285-4291.
4Rath CL,Kanfmann M,Schmid H,et al.Effect ofintraperitoneal recombinant human tumor necrosis factor alpha on malignant ascites[J].Eur J Cancer,1991,27(1):121.
5孙燕 周际昌.临床肿瘤内科手册[M].北京：人民卫生出版社,1996.138.
6卢琳 钟恒竟 张贯林.艾迪注射液药学实验[J].中华肿瘤临床,1981,(1):78-78.
7Neragi-Miandoab S. Malignant pleural effusion, current and evolving approaches for its diagnosis and management. Lung Cancer, 2006, 54 : 1-9.
8Pilch YH. Treatment of renal cell carcinoma and melanoma patients with immune RNA. J Exp Pathol, 1987, 3 : 501-514.
9Yu GR, Chen SX, Mei SW, et al. Clinical and immunologic status of viral myocarditis and its treatment. Chin Med .l (Engl), 1988, 101: 191-196.
10Marshall T, Mallett R. The influence of racial mix on comparisons of perinatal mortality rate between Area Health Authorities. Int J Epidemiol, 1980, 9: 255-263.
